Are Astron Paper latest results good or bad?

Nov 18 2025 07:32 PM IST
share
Share Via
Astron Paper's latest results are concerning, showing a complete halt in revenue generation with net sales at ₹0.00 crore and a net loss of ₹4.75 crores, indicating severe operational and financial distress. The company's outlook remains uncertain due to ongoing challenges and a significant working capital deficit.
The latest financial results for Astron Paper indicate a significant operational crisis, marked by a complete cessation of revenue generation in Q2 FY26, with net sales reported at ₹0.00 crore. This represents a stark decline from ₹35.55 crores in the same quarter of the previous year, reflecting a 100% drop year-on-year. The company also reported a net loss of ₹4.75 crores for the quarter, which, while a slight reduction from the previous quarter's loss, still underscores ongoing financial distress.

The operational metrics reveal a troubling trend, as the company has faced a continuous decline in sales since March 2024, culminating in this quarter's total operational shutdown. The return on equity has deteriorated sharply to -62.10%, indicating severe capital destruction and a challenging environment for recovery. The company's debt-to-equity ratio stands at 0.85x, suggesting moderate leverage, but this becomes increasingly problematic in light of zero revenue generation.

In terms of operational performance, the company has seen a drastic erosion of its financial position, with a working capital deficit of ₹34.46 crores, as current liabilities exceed current assets. The absence of institutional support and the complete reliance on retail investors further complicate the situation, as reflected in the lack of confidence in the company's recovery prospects.

Overall, Astron Paper's financial results paint a picture of a company in deep distress, with critical challenges ahead. The company has experienced an adjustment in its evaluation, reflecting the severity of its operational and financial difficulties. Without a clear path to restarting operations or addressing its financial burdens, the outlook remains highly uncertain.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News